Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03909178 · ClinicalTrials.gov registry record · NA

Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum

A NA study of Osteoarthritis, Hip and Hip Arthroscopy, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT03909178 is a NA study of Osteoarthritis, Hip and Hip Arthroscopy that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 110 participants, below the 1,268-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03909178, a NA study of Osteoarthritis, Hip and Hip Arthroscopy, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

Tears of the acetabular labrum appear to be common with the prevalence of asymptomatic tears in the general population approaching 66% and 70% based on cadaveric dissection and magnetic resonance imaging, respectively. Despite this prevalence, there is no currently accepted justification for performing labral repair in an asymptomatic patient despite the many postulated biomechanical benefits that an intact labrum imparts to the hip joint. Representing a smaller proportion of all tears, symptomatic tears of the acetabular labrum present a therapeutic challenge. Current treatment modalities range from conservative measures to open surgical intervention. Conservative measures have typically included: activity modification, the use of non-steroidal anti-inflammatory drugs (NSAIDs), physical therapy (PT), core strengthening and improvement of sensory motor control. In the past two decades, technological advances in the form of surgical instrumentation and traction devices have facilitated less invasive arthroscopic techniques to diagnose and treat hip problems and as such is now the preferred treatment modality for many orthopedic surgeons treating patients with hip pathology. Determining which patients, using age and arthritic burden as predictors, can benefit from labral repair is paramount for several reasons. Showing arthroscopic repair is of little or no benefit to a specific cohort can reduce the number of unnecessary surgeries performed, increase the use of conservative therapy (if validated) and reduce the interval between diagnosis and total hip replacement.

Interventions

  • PROCEDURE Hip Arthroscopy Surgery with Acetabular Labral Repair (SPT group)
  • PROCEDURE Physical Therapy Focused on the Hip and Hemi-pelvis (PT group)

Study Locations (1)

Massachusetts

  • MGH, Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2013-10-21
Est. Completion 2030-06
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03909178

The ClinicalTrials.gov registry entry for NCT03909178 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,268-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (91% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Osteoarthritis, Hip appearing as the primary indexed condition, and to 2 interventions - of which Hip Arthroscopy Surgery with Acetabular Labral Repair (SPT group) is the first listed.

NCT03909178 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03909178 about?

NCT03909178 is a clinical study titled "Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum". Tears of the acetabular labrum appear to be common with the prevalence of asymptomatic tears in the general population approaching 66% and 70% based on cadaveric dissection and magnetic resonance imaging, respectively. Despite this prevalence, there is no currently accepted justification for perform...

What is the current status of trial NCT03909178?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2013-10-21. Estimated completion is 2030-06.

What conditions does trial NCT03909178 study?

This clinical trial studies the following conditions: Osteoarthritis, Hip, Hip Arthroscopy, Physical Therapy, Femoro Acetabular Impingement, Acetabular Labrum Tear.

What interventions are being tested in trial NCT03909178?

The interventions under investigation include: Hip Arthroscopy Surgery with Acetabular Labral Repair (SPT group) (PROCEDURE), Physical Therapy Focused on the Hip and Hemi-pelvis (PT group) (PROCEDURE).

Who is sponsoring clinical trial NCT03909178?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03909178 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis, Hip

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.